| Product Information |
DR-XY42115_PI_01.pdf
|
| Registration Number |
DR-XY42115
|
| Generic Name |
Lapatinib (As Ditosylate)
|
| Brand Name |
Tykerb
|
| Dosage Strength |
250 mg
|
| Dosage Form |
Film-Coated Tablet
|
| Classification |
Prescription Drug (RX)
|
| Packaging |
HDPE bottle with two-piece child-resistant closure (Box of 70's and 84's)
|
| Pharmacologic Category |
-
|
| Manufacturer |
Glaxo Operations UK Limited Trading as Glaxo Wellcome Operations
|
| Country of Origin |
United Kingdom
|
| Trader |
|
| Importer |
Novartis Healthcare Philippines, Inc.
|
| Distributor |
Glaxo Wellcome S.A.
|
| Application Type |
-
|
| Issuance Date |
29 July 2020
|
| Expiry Date |
13 June 2025
|